Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-08-19FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Fluphenazine decanoate from Hikma Pharmaceuticals USA, indicating updated regulatory authori…
-
FDA approval · 2008-08-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE by Mylan Institutional LLC, approving the generic long-acting injectable f…
-
FDA approval · 2008-08-14FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine), adding an intramuscular formulation to the product. This…
-
FDA approval · 2008-08-14FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for risperidone from Janssen Pharmaceuticals, updating the drug's labeling.
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-08-14FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for Haloperidol Decanoate submitted by Patriot Pharmaceuticals LLC. The action concerns the approval…
-
FDA approval · 2008-08-14FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc., updating the label to reflect the appr…
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Geodon (ziprasidone mesylate) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Minocycline for the Treatment of Early-Phase Schizophrenia [Phase 3]
A Phase 3 trial evaluating minocycline for negative and cognitive symptoms in schizophrenia has completed.
-
FDA label_change · 2008-08-11FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) submitted by AstraZeneca Pharmaceuticals LP. This approval results in l…
-
CLINICAL_TRIALS trial_result · 2008-07-31Clinical Trial Update: Efficacy of Galantamine to Treat Schizophrenia [Phase 4]
A Phase 4 trial assessing galantamine for schizophrenia has been terminated, with no efficacy results reported in the snippet.
-
CLINICAL_TRIALS trial_result · 2008-07-31Clinical Trial Update: A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients [Phase 2]
A Phase 2, single-center, double-blind trial evaluating MEM 3454 for effects on P50 sensory gating and mismatch negativity in schizophrenia …
-
CLINICAL_TRIALS trial_result · 2008-07-25Clinical Trial Update: A Clinical Trial on the Antipsychotic Properties of Cannabidiol [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the antipsychotic properties of cannabidiol in schizophrenia and…
-
FDA approval · 2008-07-25FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride by Lannett Company, Inc., confirming regulatory approval for this gen…
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia [Phase 2, Phase 3]
This document reports the completion of a Phase 2/Phase 3 clinical trial evaluating oxcarbazepine as an adjunct to antipsychotic therapy in …
-
CLINICAL_TRIALS trial_result · 2008-07-23Clinical Trial Update: Efficacy of Selegiline in Negative Symptoms of Schizophrenia [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the efficacy of selegiline for negative symptoms in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone [NA]
Pfizer-sponsored trial evaluating the differential sensitivity of two spatial working memory tests in individuals with schizophrenia treated…
-
FDA approval · 2008-06-26FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions [Phase 3]
A Phase 3 clinical trial comparing two state-of-the-art interventions for treating psychotic symptoms in youth with a first episode of schiz…
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
The FOCUS trial evaluating FazaClo (clozapine) for schizophrenia has completed, with weight gain and sialorrhea noted as conditions of inter…
-
FDA approval · 2008-06-18FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Haloperidol decanoate from Hikma Pharmaceuticals USA Inc., resulting in an update to the product…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Treatment of Neuroleptic Induced Acute Akathisia With Trazodone [Phase 4]
A Phase 4 trial evaluating trazodone for treatment of neuroleptic-induced acute akathisia in schizophrenia has completed.
-
CLINICAL_TRIALS research · 2008-06-04Clinical Trial Update: Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial [Phase 4]
This document reports a completed Phase 4 randomized trial evaluating clozapine augmentation with ziprasidone or risperidone for schizophren…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients [Phase 3]
A Phase 3 trial comparing weight changes in stable schizophrenia patients treated with bifeprunox versus quetiapine has been terminated.
-
FDA approval · 2008-05-29FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., under the ANDA framework.